Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Dopamine D3-preferring partial agonist for schizophrenia and bipolar disorder. | Dopamine-stabilising antipsychotic with less weight gain. |
| Body system | Mental Health | Mental Health |
| Drug class | Second-generation antipsychotics | Second-generation antipsychotics |
| Supply | Prescription only | Prescription only |
| Main uses | Schizophrenia, Bipolar mania and depression, Add-on for major depression (US) | Schizophrenia, Bipolar disorder, Depression (add-on), Tourette's syndrome, Irritability in autism |
| How it works | Balances dopamine signalling rather than only blocking it. | Turns dopamine signalling down where it's overactive and up where it's low. |
| Starts working | Days to weeks | — |
| Half-life | 2–4 days (active metabolite 1–3 weeks) | About 75 hours |
| Typical adult dose | 1.5 mg once a day, increased to 3–6 mg (bipolar up to 6 mg). | 10–15 mg once a day (up to 30 mg); 2–5 mg as an antidepressant add-on. |
| Forms | Capsule | Tablet, Orodispersible tablet, Oral solution, Monthly or 2-monthly injection |
| Common side effects | Restlessness (akathisia), Nausea, Tremor, Insomnia, Weight gain | Restlessness (akathisia), Nausea, Insomnia, Headache |
| Serious side effects | Tardive dyskinesia, Neuroleptic malignant syndrome, Suicidal thoughts in young people, Stroke risk in older people with dementia | Impulse-control problems (gambling, shopping, eating), Neuroleptic malignant syndrome, Tardive dyskinesia |
| Don't take if | Taking strong CYP3A4 inducers; Severe kidney or liver impairment | — |
| Alcohol | Best avoided. Alcohol adds to sedation. | — |
| Pregnancy | Use with cautionLimited data. | Use with cautionUsed when needed. |
| Breastfeeding | Usually avoidedAvoid. | — |
| In use since | — | 2002 |
| Brand names | United States: VraylarUnited Kingdom: ReagilaIndia: Cariprazine (generic) | United States: Abilify, Abilify Maintena, Abilify AsimtufiiUnited Kingdom: AbilifyIndia: Arip MT, Aripra |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | N05AX15 | N05AX12 |
Taken together
- ModerateCariprazine + Aripiprazole: Added sedation
Both medicines cause drowsiness; together they impair driving, balance and breathing, especially in older people.